Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
The Romanian Ministry of Finance has announced the launch of the ninth Fidelis government bond programme for 2025, with subscriptions open from 10–17 October.
The artificial intelligence sector is rapidly reshaping the labour market in Romania, creating both opportunities and challenges for businesses and professionals.